Clinical efficacy and mechanism of Shenqi Shiyiwei granules in cancer-related anemia of Colon cancer based on network pharmacology

Corresponding author: Wang Ken, wangken6047@126.com

DOI: 10.12201/bmr.202506.00080

•  

  Abstract: Abstract Objective:To investigate the clinical efficacy and mechanism of Shenqi Shiyiwei Granules (SQSYW) in improving cancer-related anemia in colon cancer.Methods:Potential targets and core genes of SQSYW for treating colon cancer-related anemiawere identified through database and network pharmacology analyses. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were performed on the identified targets. A clinical trial enrolled 80 patients with colon cancer-related anemia,divided into a control group (40 patients) receiving conventional Western medicine (subcutaneous erythropoietin injections) and an experimental group (40 patients) receiving SQSYW in addition to the control treatment. Outcomes compared included clinical efficacy rate, Traditional Chinese Medicine (TCM) symptom scores, hemoglobin levels, and red blood cell counts.Results:Network pharmacology identified 5 key active components, 10 core targets, and 30 major pathways. The experimental group showed significantly higher red blood cell counts, hemoglobin levels, TCM symptom improvement, and overall clinical efficacy compared to the control group (P?< 0.05).Conclusion:This study reveals that SQSYW alleviates colon cancer-related anemia through a multi-component, multi-target, and multi-pathway synergistic mechanism, demonstrating superior efficacy compared to Western medicine alone.

  Key words: Network Pharmacology; Shenqi Shiyiwei Granules; Cancer-related anemia ；Colon cancer

  Submit time: 27 June 2025

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• Wei Chunshan. Exploring medication rules and mechanism for liver cancer based on data mining and network pharmacology. 2024. doi: 10.12201/bmr.202407.00040

  Yuan Zhenzhong. Mechanism of Relieves insomnia Effect of Jiaotai Pills Based on Network Pharmacology. 2024. doi: 10.12201/bmr.202408.00069

  cheng lingjing, li hetong, zhang shengxiao, liu hongqi, yu qi, zheng chaoyue, feng shuang, kong teng, sun xiangfei, he peifeng, LV Xiao-ping. Protein-based bioinformatics analysis of cervical cancer-related genes. 2023. doi: 10.12201/bmr.202303.00017

  HONG Suru, WU Xiayang. Exploring the Molecular Mechanism of Fengliao Changweikang in the Treatment of Irritable Bowel Syndrome Based on Network Pharmacology and Molecular Docking Technology. 2025. doi: 10.12201/bmr.202504.00022

  Wen yiqun, LU Lingjuan. Based on data mining and network pharmacology, this paper explores the medication rules of traditional Chinese medicine in the treatment of senile deafness. 2025. doi: 10.12201/bmr.202506.00077

  HU Jie, LIU Yun-nan. Bibliometric analysis of literatures related to colorectal cancer organoids based on CiteSpace. 2024. doi: 10.12201/bmr.202409.00036

  Wang Yeliu, Zhou Shuping. Clinical efficacy and safety of Esomeprazole combined with Biling Weitong granules in the treatment of EPS. 2025. doi: 10.12201/bmr.202501.00052

  Zhao Ruiguo, Zhou Lurong, Wang Ning▲. Discussing the pathogenesis and treatment of colorectal cancer with Iron Death on the basis of “health and evil all originate from yin and yang”.. 2025. doi: 10.12201/bmr.202505.00043

  YANG Delin. Advanced Frontiers in Diagnostic and Therapeutic Strategies for Key Genes in Prostate Cancer. 2025. doi: 10.12201/bmr.202501.00014

  Wang Yaoqiang, Wang Haohao, Luo Changjiang. The role of HMGB1 in the progression and therapy of Gastric Cancer. 2024. doi: 10.12201/bmr.202412.00009

• ID	Submit time	Number	Download
  1	2025-06-11	bmr.202506.00080V1	Download

• Public  Anonymous  To author only Submit Comments